Novo Nordisk and Eli Lilly stocks edged higher Thursday after Medicare said it could pay for weight-loss drugs for some members.

The post Medicare Will Cover Weight-Loss Drugs — For Some. Here’s What It Means For Novo, Lilly. appeared first on Investor’s Business Daily.